Regeneron Is Playing Defense With Capital Allocation
Regeneron's 2025 outlook includes defensive capital allocation, competitive pressure on Eylea, et cetera. Click here to read ...
Bellevue startup, armed with $320 million, undertakes ambitious project to aid medical research
Regeneron, San Diego-based biotech company Illumina and 17 health systems invested in the $320 million round. Regeneron ...
Workforce development hub coming to former Saint Rose campus
Gov. Hohcul announced part of Saint Rose campus will be turned into a workforce development hub as part of the ON RAMP initiative ...
FiercePharma6d
Regeneron's Libtayo reaches blockbuster status and has potential for more growth: execs
As for revenue, Regeneron reported it at $3.79 billion for the fourth quarter, which was up 10% year over year. The company's full-year haul came in at $14.2 billion, which was an increase of 8%.